RosettaMed products improve the quality and timeliness of patient information required for efficient claims processing, clinical documentation, computerized physician order entry, and effective medical management. Available for ambulatory medical practices of all sizes, as well as for hospitals and integrated delivery systems, our products help put an end to time-wasting paper shuffles and chases.

Acquired by Oregon-based Kryptiq in 2003.
Visit RosettaMed

Reasoning Mind is an innovative non-profit company specializing in middle and high school education, with an emphasis on math. The company develops and deploys Internet-based learning environments, where students solve problems, read theory material, attend virtual classroom sessions with qualified tutors, and play interactive games either alone or with their peers.

Reasoning Mind sees the Internet as a means which can be used to provide well-implemented, strong curricula to students, and to present those curricula in different ways for students with different learning styles.

Alexander R. Khachatryan, Ph.D.

(281) 579-1110
info@reasoningmind.org
Visit Reasoning Mind

Questia is the first online subscription-based research service that provides undergraduate college students unlimited access to the full text of tens of thousands of scholarly liberal arts books and journals. A wide range of tools is available to help students write and research better papers, faster and more efficiently.

The research tools allow students to quickly locate the most relevant information on their topics, automatically cite sources and instantly format bibliographies. With its holistic research environment, Questia helps students perform more thorough academic research and write better papers.

Troy Williams

(713) 358-2500
troy@tlgmedia.com
Visit Questia

Qcue is reinventing the primary ticket marketplace with the world’s only dynamic pricing engine for live entertainment events. Sports teams, concert promoters and venues use Qcue ‘s patent-pending technology to set the right price at the right time and provide the best value for fans, from the date of on-sale to the date of the event. Customers and partners include the San Francisco Giants, Dallas Stars, Major League Baseball Advanced Media, and Tickets.com.

Barry Kahn

(512) 853-9462
bk@qcue.net
Visit Qcue

Pulmotect, Inc. is a Houston-based biotechnology company, developing products that boost the innate immune system to protect against a wide range of lung infections. Our co-founders are leaders in the emerging science of innate immunity in the lungs. Our technologies stimulate the body’s natural defenses to provide safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague).

Brenton Scott

(832) 296-1779
bscott@pulmotect.com
Visit Pulmotect

PolyVista, Inc. is a software company that develops automated, high performance analytical software for the Enterprise Decision Support (“EDS”) market. Customers will use the product to automatically and interactively explore their business data, resulting in improved business process understanding, enabling better – faster decisions, and identifying new business opportunities. PolyVista software uniquely and seamlessly delivers OLAP (“On-Line Analytical Processing”) functionality, fully interactive 3D data visualization, imbedded data mining algorithms and an easy to use interface.

Shahbaz Anwar

(832) 687-9500
msanwar@yahoo.com
Visit PolyVista

PointCross develops and delivers technology solutions that transform the way companies work together. PointCross provides its “objectives-driven” contextual interaction technology as a solution to control and manage highly distributed and dispersed companies in a firm’s value-chain.

PointCross’ solution, Orchestra, is being used on complex engineering projects by global energy companies to manage contractors, vendors and suppliers, to reduce project cycle-times, costs, and exposures to risks, and to enhance the knowledge base of participating firms. PointCross has been established in SugarLand, TX to serve the needs of the energy industry globally.

PointCross is presently focused on projects in Exploration & Production, Petrochemical, Power, Pipeline and other segments of the energy and engineering industries.

Amit Bhandari

(281) 295-1900
amit@pointcross.com
Visit PointCross

PLx Pharma is a pharmaceutical company developing the next generation of non-steroidal anti-inflammatory agents (NSAIDs) that are safer on the gut. The Company is developing new formulations of currently marketed NSAIDs with enhanced safety for the pain and cardiovascular markets.

Ron Zimmerman

(713) 842-1249
ron.zimmerman@plxpharma.com
Visit PLx Pharma

Pipe Wrap, Inc. manufactures premier pipe repair systems to structurally rehabilitate US Department of Transportation (DOT) regulated pipelines, as well as those in refineries, chemical plants, and offshore. Pipe Wrap will globally dominate the composite pipe repair market using patents pending advances in composite manufacturing.

Using nanotechnology, we have increased the mechanical properties of our composite systems increase by 30%, none of our competitors will be able to attain these results. The development of the enhanced product systems are partially funded by NSF SBIR Phase I and II grant awards.

Genevieve Withers

855-655-6750
Visit Pipe Wrap

OrthoAccel Technologies, Inc. is creating a large orthodontic device market with a technology that significantly reduces the amount of time that it takes an orthodontist to straighten teeth with braces. The device, AcceleDent, includes a Mouthpiece and an Activator that delivers pulsing, vibratory forces that enhance the constant forces being applied by the traditional braces. The patient simply bites down on the device for twenty minutes daily; and the patented technology is compatible with all forms of current orthodontic treatment including Invisalign. Clinical results have been observed in a pilot study.

The Company is currently shipping product commercially to the United Kingdom, and has plans to enter Australia next, having recently secured TGA (Therapeutic Goods Administration) clearance. A pivotal trial is in field and should conclude later in 2010. Upon its completion, a 510(k) submission will be made to FDA and US clearance is anticipated in early 2011.

Michael K. Lowe

(832) 631-1660
info@orthoaccel.com
Visit OrthoAccel